Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Self-acupuncture for Migraines Feasibility Study [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 feasibility study on self-acupuncture for migraines, sponsored by the University of West Lond…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Personality, Defences, Central Sensitization, and Trauma in Women With Chronic Migraine, Fibromyalgia, and Vulvodynia
A completed clinical trial update examining personality, defences, central sensitization, and trauma in women with fibromyalgia, chronic mig…
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women
A completed clinical trial update assessing the use of triptans for migraine in individuals with elevated cardiovascular risk and in pregnan…
-
CLINICAL_TRIALS withdrawal · 2024-12-02Clinical Trial Update: Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for Preventive Treatment of Migraine [NA]
A clinical trial evaluating combined occipital and trigeminal nerve stimulation (eCOT-NS) for preventive treatment of migraine has been with…
-
FDA approval · 2024-11-26FDA Approved: TOPIRAMATE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for Topiramate submitted by NorthStar RxLLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Real-world Data Analysis of REN Treatment in Migraine Patients
Real-world data analysis of REN Treatment for migraine has been completed, summarizing observed effectiveness and safety in migraine patient…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Real-World Evidence (RWE) Data Analysis of 1-year Consecutive Use of Remote Electrical Neuromodulation (REN)
This clinical-trial update reports real-world evidence on one-year consecutive use of Theranica's Remote Electrical Neuromodulation device f…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Real World Data Analysis: Impact of High-Frequency REN Treatments As Migraine Preventive Therapy in Adolescence
This document reports a completed real-world data analysis examining the use of high-frequency remote electrical neuromodulation (REN) as a …
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: A Prospective Post-marketing Observational Study Assessing the Safety and Efficacy of Nerivio for Migraine Prevention.
A completed prospective post-marketing observational study evaluating the safety and efficacy of Nerivio for migraine prevention was conduct…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: A Survey Study to Assess the Accessibility of the Nerivio Device At School
A completed clinical trial surveyed how accessible the Nerivio migraine device is for use in school settings by children.
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Observational Study to Assess Migraine Prediction Tool
An observational study to assess a migraine prediction tool sponsored by Theranica is currently suspended.
-
FDA approval · 2024-11-21FDA Approved: DICLOFENAC SODIUM — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for a generic diclofenac sodium product from NorthStar Rx LLC.
-
FDA approval · 2024-11-21FDA Approved: TREXIMET — Supplemental Application (Currax Pharmaceuticals LLC)
FDA approved a supplemental application for TREXIMET, the combination of sumatriptan succinate and naproxen sodium, by Currax Pharmaceutical…
-
FDA approval · 2024-11-21FDA Approved: BUTALBITAL, ASPIRIN, AND CAFFEINE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved a supplemental application for a generic combination product containing butalbital, aspirin, and caffeine from Westminster Phar…
-
FDA approval · 2024-11-21FDA Approved: SUMATRIPTAN — Original Application (ONESOURCE SPECIALTY PHARMA LIMITED)
The FDA approved an original application for Sumatriptan from Onesource Specialty Pharma Limited, granting a generic form of sumatriptan. Th…
-
FDA approval · 2024-11-21FDA Approved: BUTALBITAL, ASPIRIN, AND CAFFEINE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental ANDA from Lannett Company to market a generic Butalbital, Aspirin, and Caffeine product.
-
FDA approval · 2024-11-21FDA Approved: BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE — Supplemental Application (Amneal Pharmaceuticals of New York, LLC)
FDA granted supplemental approval for Amneal's generic product containing butalbital, aspirin, caffeine, and codeine phosphate.
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Migraine and High Flow Oxygenotherapy at the Emergency Department (MiOx) [Phase 4]
A Phase 4 clinical trial (MiOx) evaluating high-flow oxygen therapy for migraine in the emergency department is currently recruiting. The st…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: "Longitudinal Analysis of Amylin Levels in Migraine Patients Undergoing an Anti- CGRP/CGRPr Treatment"
This clinical trial update describes a longitudinal analysis of amylin levels in migraine patients undergoing anti-CGRP/CGRPr treatment. The…
-
CLINICAL_TRIALS research · 2024-11-13Clinical Trial Update: Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification
This clinical trial aims to molecularly phenotype migraine patients by sex and age using CGRP quantification and is currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Efficacy of Nerve Block Versus Botox in Chronic Migraine Management [NA]
This clinical trial update reports a head-to-head comparison of nerve block versus Botox for chronic migraine management, with recruitment o…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Discussion on the Mechanism of Acupuncture on Patients with Paroxysmal Migraine Without Aura : a Randomized Controlled Clinical Trial [NA]
A randomized controlled trial is being conducted to explore the mechanism of acupuncture in patients with paroxysmal migraine without aura, …
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: Psychometric Properties of the Turkish Version of the HANA in Migraine
This study evaluates the psychometric properties of the Turkish version of the HANA instrument in individuals with migraine, reporting how w…
-
FDA approval · 2024-11-05FDA Approved: TOPIRAMATE — Original Application (Vitruvias Therapeutics, Inc.)
FDA approves Vitruvias Therapeutics' generic Topiramate through an Original Application (ANDA), expanding access as a generic option for epi…
-
CLINICAL_TRIALS research · 2024-11-04Clinical Trial Update: Investigation of Functional Brain Features in Women with Migraine
A clinical trial investigating functional brain features in women with migraine, currently recruiting.